VLP THERAPEUTICS, INC.
Biotech · Private
Virus-like particle (VLP) vaccine platform displaying inserted antigens, specifically targeting PD-L1 for cancer immunotherapy
vlptherapeutics.com →- Grants
- $597K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 5 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of a novel Virus-Like Particle vaccine-based cancer immunotherapy targeting PD-L1. | $298,729 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of a novel Virus Like Particle vaccine based cancer immunotherapy targeting PD L | $298,729 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1973 | FasCure Therapeutics LLC | — | — |
| 1974 | UBIQUITX, INC. | — | — |
| 1975 | ACCUNOVO BIOTECHNOLOGIES INC | — | — |
| 1976 | VLP THERAPEUTICS, INC. | — | — |
| 1977 | CILA THERAPEUTIC INC. | — | — |
| 1978 | Liberation Technology Services, Inc. | — | $25K |
| 1979 | GORDIAN BIOTECHNOLOGY, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Galectin-targeting Immunotherapygranted
- Alphavirus Replicon Encoding Chimeric SARS-COV-2 Receptor Binding Domainsapplication
- Alphavirus Replicon Particleapplication
- Alphavirus Replicon Encoding Chimeric SARS-COV-2 Receptor Binding Domainsgranted
- Alphavirus Replicon Particlegranted
- Cytokine Immunotherapyapplication
- Alphavirus Replicon Vector And Immunotherapy By Administering Samegranted
- Chikungunya Virus (chikv) Or Venezuelan Equine Encephalitis Virus (veev) Virus-like Particles Comprising Heterologous Antigens Inserted Into The Envelope Proteingranted
- Alphavirus Replicon Particleapplication
- Coronavirus Vaccineapplication
- Coronavirus Vaccineapplication
- Cytokine Immunotherapyapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.